Suppr超能文献

患者报告了间接硬脑膜颈动脉海绵窦瘘血管内治疗的长期结果。

Patient reported long-term outcome after endovascular therapy of indirect dural carotid cavernous fistulas.

机构信息

Institute of Neuroradiology, University Hospital, LMU Munich, Munich, Germany.

Radiologie Augsburg-Friedberg ÜBAG, Augsburg, Germany.

出版信息

PLoS One. 2020 Apr 10;15(4):e0231261. doi: 10.1371/journal.pone.0231261. eCollection 2020.

Abstract

PURPOSE

Patient-reported long-term follow-up after endovascular treatment of indirect carotid cavernous fistulas is important, but rarely addressed in literature. We report on this issue with a special focus on the patient's view and its impact on the indication evaluation process.

METHODS

We retrospectively reviewed the records of all patients (n = 33) with a minimum follow-up interval of at least 36 and up to 166 months after endovascular treatment of an indirect carotid cavernous fistula (Barrow B-D) at our institution (treated from 01/2003 to 06/2015). We determined treatment details including primary therapy success and complication rate and quote the patient's subjective perception of the long-term treatment success using a standardized interview form.

RESULTS

As a primary result the fistula was completely occluded in 25/33 cases (76%), while a downgrading was achieved in 8/33 (24%) of the cases. Secondary occlusion was observed in three out of eight patients (38%). In the long-term interview (response rate: 91%, median follow-up interval: 114 months) 87% of the patients reported high satisfaction with the long-term therapy result. Endovascular treatment achieved a sustainable relief from all eye-related symptoms in 89% and from pulsatile tinnitus in 57% of the cases.

CONCLUSIONS

In addition to good results in terms of angiographic and clinical cure, endovascular treatment is also perceived as beneficial by most of the patients. This is another important argument in favor of an endovascular treatment.

摘要

目的

患者对血管内治疗间接颈动脉海绵窦瘘(CCF)后长期随访的报告非常重要,但在文献中很少涉及。我们报告了这一问题,并特别关注患者的观点及其对适应证评估过程的影响。

方法

我们回顾性分析了我院(2003 年 1 月至 2015 年 6 月)治疗的所有间接 CCF(Barrow B-D)患者(n=33)的病历,其随访时间至少为 36 个月,最长为 166 个月。我们确定了治疗细节,包括主要治疗成功率和并发症发生率,并使用标准化访谈表评估患者对长期治疗效果的主观感受。

结果

作为主要结果,25/33 例(76%)瘘完全闭塞,8/33 例(24%)降级。8 例中有 3 例(38%)出现继发性闭塞。在长期随访(应答率:91%,中位数随访时间:114 个月)中,87%的患者对长期治疗效果表示高度满意。血管内治疗使 89%的眼部相关症状和 57%的搏动性耳鸣得到持续缓解。

结论

除了在血管造影和临床治愈方面取得良好效果外,血管内治疗也被大多数患者认为是有益的。这是支持血管内治疗的另一个重要论点。

相似文献

本文引用的文献

3
Clinically Directed Neuroimaging of Ophthalmoplegia.临床导向的眼肌麻痹神经影像学检查
Clin Neuroradiol. 2018 Mar;28(1):3-16. doi: 10.1007/s00062-017-0646-0. Epub 2017 Nov 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验